EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Constructing Activatable Photosensitizers Using Covalently Modified Mesoporous Silica

Yan Liu, Xiang Wang, Ben Wang, Zhenni Lu, Changru Wu, Zhanghao He, Libo Jiang, Peng Wei, Tao Yi iD

Advanced Science · 2025-03 · 12 (9)

DOI: 10.1002/advs.202406887 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 15.01.2025. Verfasst von Yan Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Chemistry and Chemical Engineering, Donghua University, Sh…. Hauptthemen laut MEDLINE: Silicon Dioxide, Photosensitizing Agents, Photochemotherapy. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Medical Engineering fund of Fudan University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The combination of photosensitizers (PSs) and nanomaterials is a widely used strategy to enhance PS efficacy and broaden their applicability. However, the current nanocarrier‐based delivery strategies focus on conventional PSs, neglecting the critical issue of PS phototoxicity. In this study, DHUOCl‐25, an activatable PS (aPS) activated by hypochlorous acid, is synthesized by combining a silicon source structure and an activation unit. DHUOCl‐25 functions as a silica source for synthesizing activatable mesoporous silica nanostrctures (MSNs) using a standardized protocol, enabling the synthesis of aPS‐covalently modified MSNs for a variety of biologic therapeutic applications. On one hand, the resulting nano‐aPS maintains aPS functionality for antibacterial application by achieving synergistic antibacterial action via MB PDT and retained cetyltrimethylammonium bromide (CTAB) (antibacterial agent) (DHU–MSNs‐2). On the other hand, the nano‐aPS exhibits MSN properties for drug loading, facilitating the synergistic integration of photodynamic therapy with chemotherapy (DHU–MSNs‐6) of tumors and demonstrating efficacy against the spinal metastases of lung cancer. These results validate this strategy for developing novel aPSs and expanding the application of aPSs and MSNs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Silicon DioxidePhotosensitizing AgentsPhotochemotherapyAnimalsHumansMicePorosityAnti-Bacterial AgentsCetrimonium

Stichwörter der Autor:innen

activatable photosensitizercombination therapymesoporous silicaphotodynamic therapy

Substanzen

Silicon DioxidePhotosensitizing AgentsAnti-Bacterial AgentsCetrimonium

Autor:innen und Institutionen

  • State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Chemistry and Chemical Engineering, Donghua University, Shanghai, 201620, China.
  • Department of Orthopaedic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.

ORCID-Profile: Tao Yi

Förderung

  • National Key R&D Program of China
  • Medical Engineering fund of Fudan University
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Liu, Y., Wang, X., Wang, B., Lu, Z., Wu, C., He, Z., Jiang, L., Wei, P., & Yi, T. (2025). Constructing Activatable Photosensitizers Using Covalently Modified Mesoporous Silica. Advanced Science, 12(9). https://doi.org/10.1002/advs.202406887

Vancouver

Liu Y, Wang X, Wang B, Lu Z, Wu C, He Z, et al. Constructing Activatable Photosensitizers Using Covalently Modified Mesoporous Silica. Advanced Science. 2025;12(9). doi:10.1002/advs.202406887

BibTeX
@article{Liu2025,
  author = {Liu, Yan and Wang, Xiang and Wang, Ben and Lu, Zhenni and Wu, Changru and He, Zhanghao and Jiang, Libo and Wei, Peng and Yi, Tao},
  title = {Constructing Activatable Photosensitizers Using Covalently Modified Mesoporous Silica},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {9},
  doi = {10.1002/advs.202406887}
}
Kostenlos starten →